Aave DAO Considers Annual $50 Million AAVE Buyback
- Aave DAO Proposes Annual Revenue-Funded Buyback
- Weekly AAVE purchases between $250 and $1,75 million
- Plan reinforces Aavenomics and creates consistent demand
The Aave Chan Initiative (ACI), led by Marc Zeller, has submitted a proposal to the Aave DAO to establish a permanent $50 million annual AAVE buyback program, fully funded by protocol revenue. The idea is to make buybacks an ongoing pillar of Aavenomics, adding predictable buying pressure to the token and optimizing treasury allocation.
According to the text, the Financial Committee (AFC) and TokenLogic would be responsible for execution, with weekly ranges between $250.000 and $1,75 million in AAVE purchases in the market. The design provides flexibility to adjust volumes according to the protocol's cash availability and market conditions, avoiding price distortions and preserving capital efficiency.
“With the completion of the existing buyback initiative and the strong success of the program, we believe it is an opportune time to enshrine a buyback program to further enhance Aavenomics,”
states the proposal. Aave's recent revenue generation history is cited as a basis for supporting the measure without compromising growth initiatives.
The plan also authorizes the AFC to leverage BTC and ETH reserves in complementary strategies, such as creating collateralized debt and yield-generating conversions, expanding the treasury's ability to capture opportunities without diluting holders. This move parallels a broader trend in DeFi, where protocols have been institutionalizing buybacks to align incentives and capture value on a recurring basis.
Aave is solidifying its position among the industry's largest protocols, recently surpassing the $25 billion mark in outstanding loans and diversifying its products. Highlights include Horizon, a credit platform backed by tokenized real-world assets, and the first implementation outside the EVM ecosystem, on Aptos, which expands its reach to new audiences.
In collateral management, the protocol has begun integrating yield-bearing assets from Maple Finance as a new type of collateral, strengthening its offering for institutional participants. Despite the recent market downturn—and a slight daily decline in AAVE—the proposal seeks to anchor structural demand and provide predictability to the capital policy under Aave DAO governance.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Betting Big on AI Burns Through Cash Cows—This Time, the Market No Longer "Rewards Burning Money"!
The AI spending race faces profitability scrutiny: Google’s search advertising growth rate has dropped to its lowest in five quarters, and Amazon’s single-quarter free cash flow has plunged to -$33.5 billion. Yet both companies continue with capital expenditure plans exceeding $400 billion. As their core cash-generating businesses lose momentum and debt and financing needs surge, the market is shifting from rewarding AI investment to questioning returns, forcing a re-evaluation of the valuation logic for tech giants.

Wall Street Sees AWS’s Ambition, But Can’t See the Future of Amazon’s Advertising Business
Amazon's Q3 financial report presents a mixed picture: AWS order backlog soared by 189% to $578 billion, and the CEO made the rare promise that growth will exceed 40% in 2027-2028, aiming for $1 trillion in revenue within five to ten years. However, advertising business growth plunged from 26% to 12%, and capital expenditure reached $77.3 billion, far exceeding expectations, causing the stock price to fall 7% after hours. While major Wall Street banks collectively maintain their “buy” ratings, they admit that the structural risks posed by AI agents to the advertising ecosystem remain unresolved.
Both Investment and Exports Lag Behind! France's Q3 GDP Unexpectedly Shrinks, Making Fiscal Consolidation Even Harder
Amid soaring borrowing costs, violent protests, and uncertainties in politics and budgeting, the French economy unexpectedly contracted in the third quarter.

A growth trump card beyond AI trading! Eli Lilly (LLY.US) sees volume boost in weight-loss drugs and launches new products; JPMorgan raises target price to $1650
Leading U.S. healthcare company Eli Lilly surged 6.63% to close at $1,373.70, defying the broader decline as the Nasdaq 100 Index fell 1.38% and the Philadelphia Semiconductor Index dropped 1.42%.
